51. OC-0573: Development of hypoxia gene signatures as biomarkers for treatment stratification. (May 2017) Authors: West, C.; Yang, L.; Roberts, D.; Bibby, B.; Forker, L.; Haider, S.; Buffa, F.; Choudhury, A. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
52. OC-0598 Hypoxia can impair cell migration due to extracellular matrix compositional and structural changes. (May 2022) Authors: Guerrero Quiles, C.; Gonzalez Abalos, J.; Humphries, J.; Humphries, M.; Whetton, A.; Choudhury, A.; West, C. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
53. OC-0639 Towards personalised treatment for prostate cancer: biology improves image-based data mining models. (August 2021) Authors: Shortall, J.; Vasquez Osorio, E.; McWilliam, A.; Green, A.; Choudhury, A.; Hoskin, P.; West, C.; Lane, B.; Elumalai, T.; Thiruthaneeswaran, N.; Bibby, B.; Rodrigues Pereira, R.; van Herk, M. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
54. OC-0647 Analysis of biomarkers for late radiotherapy toxicity in the REQUITE project. (April 2019) Authors: Talbot, C.; Azria, D.; Burr, T.; Chang-Claude, J.; Dunning, A.; Jacquet, M. Farcy; Herskind, C.; De Ruysscher, D.; Elliott, R.; Gutiérrez-Enríquez, S.; Lambin, P.; Müller, A.; Rancati, T.; Rattay, T.; Rosenstein, B.; Seibold, P.; Valdagni, R.; Vega, A.; Veldeman, L.; Veldwijk, M. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
55. OC-1031: The radiosensitivity index predicts benefit from HDR brachytherapy in high-risk prostate cancer. (November 2020) Authors: Thiruthaneeswaran, N.; Bibby, B.A.S.; Pereira, R.; More, E.; Denley, H.; Henry, A.; Wylie, J.; Hoskin, P.; Bristow, R.; Choudhury, A.; West, C. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S1086 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
56. Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip. (April 2019) Authors: Bessette, L.; Schnitzer, T.; Khan, A.; Pixton, G.; Viktrup, L.; Davignon, I.; Tive, L.; Brown, M.; West, C. Journal: Osteoarthritis and cartilage Issue: Volume 27(2019)Supplement 1 Page Start: S85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
57. OP0090 EFFICACY OF SUBCUTANEOUS TANEZUMAB FOR THE TREATMENT OF CHRONIC LOW BACK PAIN: AN ANALYSIS OF BRIEF PAIN INVENTORY-SHORT FORM SCORES FROM A 56-WEEK, RANDOMIZED, PLACEBO- AND TRAMADOL-CONTROLLED, PHASE 3 TRIAL. (2nd June 2020) Authors: Markman, J.; Perrot, S.; Ohtori, S.; Schnitzer, T.; Beydoun, S.; Viktrup, L.; Yang, R.; Bramson, C.; West, C.; Verburg, K. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
58. Pain reduction in either the knee or the hip with subcutaneous tanezumab: a pooled analysis in patients with moderate to severe osteoarthritis and a history of inadequate response to other analgesics. (April 2021) Authors: Hochberg, M.; Conaghan, P.; Yang, R.; Donevan, S.; West, C.; Verburg, K.M. Journal: Osteoarthritis and cartilage Issue: Volume 29(2021)Supplement 1 Page Start: S247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
59. Particle-flow reconstruction and global event description with the CMS detector. (6th October 2017) Authors: Sirunyan, A.M.; Tumasyan, A.; Adam, W.; Asilar, E.; Bergauer, T.; Brandstetter, J.; Brondolin, E.; Dragicevic, M.; Erö, J.; Flechl, M.; Friedl, M.; Frühwirth, R.; Ghete, V.M.; Hartl, C.; Hörmann, N.; Hrubec, J.; Jeitler, M.; König, A.; Krätschmer, I.; Liko, D. Journal: Journal of instrumentation Issue: Volume 12:Number 10(2017:Oct.) Page Start: P10003 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
60. Patient Involvement in the Design of a Phase III Trial Comparing Intensity-modulated Proton Therapy and Intensity-modulated Radiotherapy for Oropharyngeal Cancer. Issue 5 (May 2018) Authors: Hague, C.; Foran, B.; Hall, E.; Guild, S.; Joseph, O.; Moule, R.; Nutting, C.; Parsons, S.; Prestwich, R.; Slevin, N.; West, C.; Thomson, D. Journal: Clinical oncology Issue: Volume 30:Issue 5(2018) Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗